In 2015, the Chinese Society of Hepatology and the Chinese Society of Gastroenterology published a consensus on primary ...
Hosted on MSN2mon
What To Know About Primary Biliary Cholangitis (PBC)Primary biliary cholangitis (PBC), also known as primary biliary cirrhosis, is a chronic and progressive disease that damages and can eventually destroy the bile ducts of the liver. Researchers ...
Primary biliary cirrhosis (PBC) is a chronic, cholestatic liver disease characterized by progressive destruction of intrahepatic bile ducts, resulting in chronic cholestasis, portal inflammation ...
Explore the causes of itching in liver diseases and tips to relieve discomfort. Learn about treatments for pruritus and when ...
Primary Biliary Cholangitis Therapeutics Market to Reach $1.36 Billion by 2032, Growing at 7.1% CAGR
The global primary biliary cholangitis therapeutics market size was valued at US$732.5 million in 2023 and is projected to reach US$1358.1 billion by 2032, growing at a CAGR of 7.1% from 2024 to 2032.
The association between celiac disease and primary biliary cirrhosis is well established. The breakdown of gut–liver axis equilibrium plays a central role in the development of immune disorders ...
13d
StyleCaster on MSNMichelle Trachtenberg Addressed Claims She Looked ‘Sick' Months Before Her DeathHollywood is mourning the loss of another young life, and with the news of Michelle Trachtenberg’s death, there have been a ...
11d
Everyday Health on MSNWhy Do Younger Adults Need Liver Transplants?Michelle Tratchenberg, 39, had received a liver transplant in the months leading up to her death. While a cause of death has ...
Gilead Sciences, Inc. has received conditional marketing authorization from the European Commission (EC) for Seladelpar for the treatment of primary biliary cholangitis (PBC) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results